HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 384 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $28,352,256 | -38.7% | 742,400 | -8.7% | 0.41% | -33.1% |
| Q4 2022 | $46,242,630 | +25.7% | 812,700 | -12.7% | 0.61% | +16.3% |
| Q3 2022 | $36,792,000 | -13.9% | 930,500 | -4.2% | 0.53% | -12.6% |
| Q2 2022 | $42,737,000 | +4.6% | 971,300 | -5.2% | 0.60% | +27.4% |
| Q1 2022 | $40,845,000 | -4.8% | 1,024,200 | -4.1% | 0.47% | +7.2% |
| Q4 2021 | $42,924,000 | +14.5% | 1,067,500 | +15.8% | 0.44% | +16.3% |
| Q3 2021 | $37,487,000 | -62.9% | 921,500 | -58.6% | 0.38% | -61.5% |
| Q2 2021 | $101,013,000 | -19.6% | 2,224,466 | -26.1% | 0.99% | -25.8% |
| Q1 2021 | $125,569,000 | -27.3% | 3,011,966 | -25.5% | 1.33% | -32.8% |
| Q4 2020 | $172,762,000 | +20.2% | 4,045,000 | -26.0% | 1.98% | -0.4% |
| Q3 2020 | $143,729,000 | -20.3% | 5,469,131 | -18.7% | 1.99% | -22.2% |
| Q2 2020 | $180,446,000 | +30.9% | 6,730,552 | -12.2% | 2.55% | -4.5% |
| Q1 2020 | $137,874,000 | -3.2% | 7,663,956 | -4.6% | 2.67% | +18.4% |
| Q4 2019 | $142,493,000 | +14.6% | 8,036,856 | +0.3% | 2.26% | -2.3% |
| Q3 2019 | $124,303,000 | -12.3% | 8,014,356 | -2.8% | 2.31% | -4.4% |
| Q2 2019 | $141,698,000 | +9442.0% | 8,247,860 | +10781.1% | 2.42% | +1545.6% |
| Q1 2018 | $1,485,000 | -4.8% | 75,800 | -1.6% | 0.15% | -9.8% |
| Q4 2017 | $1,560,000 | +2.5% | 77,000 | -12.1% | 0.16% | +2.5% |
| Q3 2017 | $1,522,000 | -45.8% | 87,600 | -60.0% | 0.16% | -52.1% |
| Q2 2017 | $2,808,000 | -19.7% | 219,000 | -18.9% | 0.33% | -28.8% |
| Q1 2017 | $3,499,000 | +11.4% | 270,000 | -15.1% | 0.47% | -27.5% |
| Q4 2016 | $3,142,000 | -18.2% | 318,000 | 0.0% | 0.64% | -7.3% |
| Q3 2016 | $3,841,000 | +40.0% | 318,000 | 0.0% | 0.69% | +34.5% |
| Q2 2016 | $2,744,000 | -8.9% | 318,000 | 0.0% | 0.52% | -5.5% |
| Q1 2016 | $3,011,000 | – | 318,000 | – | 0.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
| BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
| SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
| Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
| Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
| PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
| Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
| Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |